These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension. Palmieri V, Devereux RB. Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398 [Abstract] [Full Text] [Related]
3. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823 [Abstract] [Full Text] [Related]
4. [Course of the left ventricular mass in a population of 893 hypertensive patients. Effects of treatment with perindopril]. Revel F, Gallois H, Le Coz Y, Richard R, Ollivier JP. Ann Cardiol Angeiol (Paris); 1994 Dec; 43(10):594-9. PubMed ID: 7864552 [Abstract] [Full Text] [Related]
5. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension]. De Simone R, Irace L, Perna B, Caruso C, Guida M, Iacono A. Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860 [Abstract] [Full Text] [Related]
7. Effect of perindopril and metoprolol on left ventricular hypertrophy and performance in essential hypertension. Hui Y, Dai Z, Chen X, Wang W. Chin Med J (Engl); 1995 Sep; 108(9):678-81. PubMed ID: 8575234 [Abstract] [Full Text] [Related]
8. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan. Avanza AC, El Aouar LM, Mill JG. Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284 [Abstract] [Full Text] [Related]
9. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension. Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B. Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311 [Abstract] [Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors influence left ventricular mass and function independently of the antihypertensive effect. Grandi AM, Laurita E, Solbiati F, Marchesi C, Maresca AM, Nicolini E, Guasti L, Venco A. J Cardiovasc Pharmacol; 2006 Nov; 48(5):207-11. PubMed ID: 17110802 [Abstract] [Full Text] [Related]
17. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy. Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H. Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684 [Abstract] [Full Text] [Related]